Mass General Brigham Health Plan announced it will drop Dana-Farber Cancer Institute from its Medicare Advantage network effective Oct. 1, a decision attributed by senior vice president Jennifer St. Thomas to limited federal reimbursements and rising care costs. According to patients and health consultants, the move leaves roughly 250 individuals currently undergoing active cancer treatment scrambling for coverage while exposing a deepening structural split between the two prominent Boston institutions.
Why Mass General Brigham Dropped Dana-Farber From Medicare Advantage
According to Jennifer St. Thomas, MGB Health Plan’s senior vice president of commercial and Medicare markets, the network change is driven by financial considerations in a challenging environment where Medicare Advantage plans argue federal reimbursements fail to keep pace with expenses. An MGB spokesperson stated that the insurance unit operates separately from the healthcare provider side for legal and business reasons.
The decision affects approximately 1,000 members who had or are slated to have appointments at Dana-Farber this year, with about 250 members actively receiving radiation or chemotherapy, according to a Dana-Farber spokesperson. David E. Williams, president of Boston management consulting firm Health Business Group, noted that the move fits a broader pattern of MGB attempting to capture regional cancer business. A Dana-Farber spokesperson stated this marks the first time in memory that a health insurer has removed the cancer institute from its network.
Pro Tip for Patients: Patients can maintain in-network coverage of Dana-Farber providers for 90 days or through the end of their treatment plans, which can extend past the start of the year for chemotherapy, radiation, cell therapy, or clinical trials, according to member letters.
Impact on Cancer Patients Facing Coverage Uncertainty
For policyholders like Eldon Clingan of Dedham, the sudden shift has sparked severe anxiety over maintaining access to specialized care. Clingan was diagnosed with prostate cancer in 1999, relapsed in 2003, and relies on an ongoing $10,000-per-month drug regimen to keep the disease managed.
Clingan and his wife are weighing a difficult choice: remain with MGB Health Plan to secure coverage for their expensive medication while losing a trusted doctor of 23 years, or switch to a new insurance plan that includes Dana-Farber while risking out-of-pocket costs for life-sustaining drugs. "It could bankrupt us if we can’t get coverage for the medicine," Carol Clingan said according to interview details. MGB Health Plan has directed affected members toward alternative providers still within its Medicare Advantage network, including the Mass General Brigham Cancer Institute, UMass Memorial Health, and Southcoast Health.
The Broader Institutional Split Between Boston Health Giants
The insurance network reduction coincides with the public unraveling of a longtime partnership in which Dana-Farber provided inpatient cancer treatment to Mass General Brigham patients. The collaboration previously propelled Dana-Farber, in partnership with MGB’s Brigham and Women’s Hospital, to a top ranking by U.S. News and World Report as the leading cancer hospital in Boston and third-best nationwide.
The institutional partnership is slated to end in 2028. Dana-Farber plans to construct a new cancer hospital in alliance with MGB rival Beth Israel Lahey Health, while Mass General Brigham intends to invest $400 million into its own standalone cancer institute.
Did You Know? Dana-Farber holds a special designation from the Centers for Medicare and Medicaid Services recognizing its complex patient population and specialized care, making it one of only 11 hospitals nationwide to receive higher Medicare reimbursements.
Medicare Advantage Narrow Networks and Financial Pressures
Private insurers offering Medicare Advantage plans utilize narrow networks to control expenditures, leveraging their ability to negotiate lower rates or limit covered providers. Williams explained that because certain hospitals carry much higher costs than others, narrowing provider networks enables insurers to make material reductions to their own costs, which can then fund richer benefits or lower premiums.
The policy shift applies strictly to Medicare Advantage, which accounts for about 5 percent of the more than 400,000 people insured by MGB Health Plan. MGB Health Plan confirmed that its MassHealth and commercial options will maintain access to Dana-Farber, and noted that Dana-Farber has never been in-network for plans serving dual-eligible Medicare and Medicaid beneficiaries.
Frequently Asked Questions
When does the removal of Dana-Farber from the MGB Medicare Advantage network take effect?
The network change begins Oct. 1, though patients can utilize a 90-day grace period or maintain coverage through the end of active treatment plans.
Are all MGB insurance plans dropping Dana-Farber?
No. MGB Health Plan’s commercial options and MassHealth plans will continue to maintain access to Dana-Farber.
What alternative providers are available within the MGB Medicare Advantage network?
MGB Health Plan directs members to alternative in-network providers including the Mass General Brigham Cancer Institute, UMass Memorial Health, and Southcoast Health.
How can affected patients get help with insurance options or financial counseling?
Dana-Farber has made financial counselors available to patients and provided lists of alternative Medicare Advantage plans that include the cancer institute in their provider networks.
Join the Discussion: Are you or a loved one affected by changes to Medicare Advantage provider networks? Share your perspective in the comments below, subscribe to our newsletter for ongoing healthcare coverage updates, and explore our related reporting on Boston health systems.
Worth a look